Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Laekna Announces Poster Presentation on Internally-Discovered Antibody for NASH/Liver Fibrosis at NASH-TAG 2024 2024-01-04 12:40
IASO BIO Announces New Development Partnership with Umoja Biopharma to Develop Ex Vivo and In Vivo Cell and Gene Therapies 2024-01-04 05:30
GPN Vaccines Reports Positive Safety and Immunogenicity Data from its Phase 1 Trial of Gamma-PN 2024-01-04 04:30
MediLink Therapeutics Announces Worldwide Collaboration and License Agreement with Roche to develop next-generation antibody drug conjugate in Oncology 2024-01-02 22:00
YolTech Therapeutics to Present and Unveil Major Progress at Biotech Showcase 2024 2024-01-02 20:30
Mabwell to attend 42nd JP Morgan Healthcare Conference and present at Biotech Showcase 2024-01-02 17:15
TiumBio Secures KRW 38.5 Billion in Anticipation of Upcoming Clinical Data 2023-12-29 21:00
Caliway to Present CBL-514 Phase 2 Study Results for Subcutaneous Fat Reduction at IMCAS 2024 2023-12-27 11:49
Jemincare Announces 6 Approvals of Clinical Trials for its Innovative Drugs 2023-12-26 17:26
PharmaBlock Obtained ISO 50001 Certification, Advancing Sustainable Development 2023-12-26 11:00
Harbin City Pushes for Breakthroughs in Full Revitalization of Northeast China 2023-12-25 20:42
FDA Keynote Speaker in the Spotlight, CAR-T Industry Leaders Gather for Discussion-Join the 2024 GenScript Biotech Global Forum for a New Journey in Cell and Gene Therapy 2023-12-25 10:15
GenSci Launches Global Innovation Hub in Shanghai 2023-12-23 15:41
TransThera Announces the Global Multicenter Phase 3 Clinical Trial Completed First Patient Dosing in the US Evaluating Tinengotinib in FGFRi Relapsed/Refractory Patients with Cholangiocarcinoma 2023-12-21 21:45
BioCity announces the first patient dosed with its anti-TIM-3 mAb BC3402 in Combination with IMFINZI for the Treatment of Advanced Hepatocellular Carcinoma in a Phase Ib/II Trial 2023-12-21 08:26
YS Biopharma Responds to Unauthorized Press Release Regarding Extraordinary General Meeting 2023-12-21 05:30
/DISREGARD RELEASE: YS Biopharma/ 2023-12-21 05:15
Genevoyager Unveils Gene Therapy CDMO Facility in Milestone Move 2023-12-20 23:10
HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharmaceuticals to Showcase Ongoing Parkinson's Disease Program at the 7th Annual Sachs Associates Neuroscience Innovation Forum 2023-12-20 20:00
InxMed Enters License Agreement with Escugen to Develop Next-Generation ADCs 2023-12-20 09:00
1 29 30 31 32 33 222